tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

INMB Stock Latest News

INmune Bio presents data on INB03’s role as immune check point
The FlyINmune Bio presents data on INB03’s role as immune check point
12d ago
INMB
INmune Bio Inc. to Report Fourth Quarter 2023 Financial Results and Provide a Corporate Update on Thursday, March 28
PremiumPress Releases
INmune Bio Inc. to Report Fourth Quarter 2023 Financial Results and Provide a Corporate Update on Thursday, March 28
24d ago
INMB
INmune Bio reports ‘significant’ EEG improvement in patients treated with Xpro
PremiumThe Fly
INmune Bio reports ‘significant’ EEG improvement in patients treated with Xpro
2M ago
INMB
INmune Bio Reports Significant EEG Improvement in Alzheimer’s Patients Treated with XPro™
PremiumPress Releases
INmune Bio Reports Significant EEG Improvement in Alzheimer’s Patients Treated with XPro™
2M ago
INMB
INmune Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
PremiumPress Releases
INmune Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
2M ago
INMB
INmune Bio to Participate in Baird’s Biotech Discovery Series Webcast on February 13, 2024
PremiumPress ReleasesINmune Bio to Participate in Baird’s Biotech Discovery Series Webcast on February 13, 2024
2M ago
INMB
Inmune Bio Resumes Alzheimer’s Trial, Aims for Mid-2024 Enrollment
PremiumCompany Announcements
Inmune Bio Resumes Alzheimer’s Trial, Aims for Mid-2024 Enrollment
3M ago
8K
INMB
INmune Bio Announces FDA Removal of Clinical Hold for Alzheimer’s Disease Program
PremiumPress Releases
INmune Bio Announces FDA Removal of Clinical Hold for Alzheimer’s Disease Program
3M ago
INMB
INmune Bio announces FDA removal of clinical hold for Alzheimer disease program
PremiumThe Fly
INmune Bio announces FDA removal of clinical hold for Alzheimer disease program
3M ago
INMB
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
MOR
ALLK
Elevai Labs signs worldwide license agreement with INmune Bio
PremiumThe Fly
Elevai Labs signs worldwide license agreement with INmune Bio
3M ago
ELAB
INMB
INmune Bio doses first patient in Phase 1/2 study of INKmune
PremiumThe Fly
INmune Bio doses first patient in Phase 1/2 study of INKmune
4M ago
INMB
INmune Bio Announces First Patient Dosed in a Phase 1/2 Study of INKmune™ in Patients with Metastatic Castration-Resistant Prostate Cancer
PremiumPress ReleasesINmune Bio Announces First Patient Dosed in a Phase 1/2 Study of INKmune™ in Patients with Metastatic Castration-Resistant Prostate Cancer
4M ago
INMB
INmune Bio announces Alzheimer’s trial remains on hold
PremiumThe Fly
INmune Bio announces Alzheimer’s trial remains on hold
4M ago
INMB
INmune Bio Provides Update Regarding Global Alzheimer’s Phase II Clinical Trial and Clinical Hold Issued by the United States FDA
PremiumPress Releases
INmune Bio Provides Update Regarding Global Alzheimer’s Phase II Clinical Trial and Clinical Hold Issued by the United States FDA
4M ago
INMB
INmune Bio announces presentation on use of INB03
PremiumThe Fly
INmune Bio announces presentation on use of INB03
5M ago
INMB
INmune receives EMA authorization in France, Spain for Phase II trial of XPro
PremiumThe Fly
INmune receives EMA authorization in France, Spain for Phase II trial of XPro
5M ago
INMB
INmune Bio announces expansion of Phase II trial for AD in Europe
PremiumThe Fly
INmune Bio announces expansion of Phase II trial for AD in Europe
5M ago
INMB
INmune Bio Inc. Announces Expansion of Phase II Clinical Trial for Alzheimer’s Disease in Europe
PremiumPress Releases
INmune Bio Inc. Announces Expansion of Phase II Clinical Trial for Alzheimer’s Disease in Europe
5M ago
INMB
INmune Bio Inc. Announces Third Quarter 2023 Results and Provides Business Update
PremiumPress ReleasesINmune Bio Inc. Announces Third Quarter 2023 Results and Provides Business Update
6M ago
INMB
INmune Bio updates on patent covering INB16, INKmune therapeutic composition
PremiumThe Fly
INmune Bio updates on patent covering INB16, INKmune therapeutic composition
6M ago
INMB
INmune Bio Inc. Patent Claims Covering INB16 Cell Line and INKmune™ Therapeutic Composition given Favorable Patentability Opinion by International Search Authority
PremiumPress Releases
INmune Bio Inc. Patent Claims Covering INB16 Cell Line and INKmune™ Therapeutic Composition given Favorable Patentability Opinion by International Search Authority
6M ago
INMB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >